Skip to main content
Clinical Trials/NCT07265050
NCT07265050
Not yet recruiting
Not Applicable

Comparison of Emergence Agitation Between Remimazolam With Flumazenil and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Nasal Surgery: A Randomized Controlled Trial

Seoul National University Hospital0 sites204 target enrollmentStarted: January 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
204
Primary Endpoint
Incidence of Emergence Agitation

Overview

Brief Summary

Participants will be randomly assigned to receive general anesthesia with either remimazolaml-based total intravenous anesthesia reversed with flumazenil or propofol-based total intravenous anesthesia. The primary outcome is the incidence of emergence agitation evaluated at the time of awakening after surgery. Additional outcomes include time to extubation, hemodynamic stability, airway complications such as coughing or laryngospasm, and postoperative recovery profiles including pain, nausea, vomiting, and sedation in the post-anesthesia care unit. This study aims to determine whether remimazolam with flumazenil provides smoother emergence compared with propofol in patients undergoing nasal surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Remimazolam

Experimental

Participants receive general anesthesia induced and maintained with remimazolam-based total intravenous anesthesia. At the end of surgery, flumazenil (0.2-1.0 mg) is administered to reverse the sedative effect.

Intervention: Remimazolam with Flumazenil (Drug)

Propofol

Active Comparator

Participants receive general anesthesia induced and maintained with propofol.

Intervention: Propofol (Drug)

Outcomes

Primary Outcomes

Incidence of Emergence Agitation

Time Frame: From discontinuation of anesthesia to exit in the operating room

Secondary Outcomes

  • Time to Tracheal Extubation(From anesthesia discontinuation to extubation in the operating room)
  • Intraoperative Hemodynamic Stability(During anesthesia)
  • Incidence of Airway Complications During Emergence(during anesthesia)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials